Reduced susceptibility to carbapenems in Klebsiella pneumoniae clinical isolates associated with plasmid-mediated β-lactamase production and OmpK36 porin deficiency
- 1 September 2009
- journal article
- research article
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 58 (9) , 1196-1202
Abstract
Two carbapenem-non-susceptibleKlebsiella pneumoniaeisolates, Z2554 and Z2110, were collected from a hospital in China and analysed by PFGE.K. pneumoniaeZ2554 and Z2110 were genetically unrelated and showed resistance to ertapenem, and reduced susceptibility to imipenem and meropenem. Analysis of theirβ-lactamases indicated thatK. pneumoniaeZ2554 produced TEM-1 and CTX-M-14β-lactamases, whilst Z2110 produced a plasmid-mediated AmpCβ-lactamase, DHA-1, in addition to TEM-1 and CTX-M-14. SDS-PAGE analysis of the outer-membrane proteins (OMPs) revealed that both isolates lacked an OMP of ∼39 kDa (OmpK36), whilst Z2110 had an additional protein with an approximate molecular mass of 26 kDa. Analysis of the OMP-encoding genes demonstrated that theompK35sequence ofK. pneumoniaeZ2554 and Z2110 contained a number of silent mutations. InompK36, several insertions and deletions of short DNA fragments (1–6 bp) were detected in both isolates. The N-terminal sequence of the ∼26 kDa protein band identified in Z2110 had no similarity to the sequence of OmpK36. Instead, it shared high similarity with hypothetical protein KPN_03267 originating fromK. pneumoniae subsp.pneumoniaeMGH 78578. It was concluded thatβ-lactamase production combined with OmpK36 deficiency results in ertapenem resistance, and reduced imipenem and meropenem susceptibility, inK. pneumoniaeZ2554 and Z2110. OmpK36 may play an important role in the resistance or reduced susceptibility to carbapenems inK. pneumoniaeproducing AmpC, extended-spectrumβ-lactamase or broad-spectrumβ-lactamase.Keywords
This publication has 31 references indexed in Scilit:
- Emergence of Serratia marcescens , Klebsiella pneumoniae , and Escherichia coli Isolates Possessing the Plasmid-Mediated Carbapenem-Hydrolyzing β-Lactamase KPC-2 in Intensive Care Units of a Chinese HospitalAntimicrobial Agents and Chemotherapy, 2008
- Plasmid-Mediated KPC-2 in a Klebsiella pneumoniae Isolate from ChinaAntimicrobial Agents and Chemotherapy, 2007
- Resistance of strains producing extended-spectrum β-lactamases and genotype distribution in ChinaJournal of Infection, 2007
- High-Level Carbapenem Resistance in a Klebsiella pneumoniae Clinical Isolate Is Due to the Combination of bla ACT-1 β-Lactamase Production, Porin OmpK35/36 Insertional Inactivation, and Down-Regulation of the Phosphate Transport Porin PhoEAntimicrobial Agents and Chemotherapy, 2006
- Characterization of a Large Outbreak by CTX-M-1-Producing Klebsiella pneumoniae and Mechanisms Leading to In Vivo Carbapenem Resistance DevelopmentJournal of Clinical Microbiology, 2006
- First IMP-1-producing Klebsiella pneumoniae isolate in TurkeyClinical Microbiology and Infection, 2006
- Role of Klebsiella pneumoniae OmpK35 Porin in Antimicrobial ResistanceAntimicrobial Agents and Chemotherapy, 2003
- Expression of SHV-2 β-Lactamase and of Reduced Amounts of OmpK36 Porin in Klebsiella pneumoniae Results in Increased Resistance to Cephalosporins and CarbapenemsAntimicrobial Agents and Chemotherapy, 2002
- Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain ofKlebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 2001
- The Use of Analytical Isoelectric Focusing for Detection and Identification of -LactamasesJournal of General Microbiology, 1975